Combining Gut Microbiota Data with Network Pharmacology to Explore the Mechanism of Danggui Sini Decoction Action Against Blood Stasis Syndrome in Rats

被引:0
|
作者
Yu, Fengfeng [1 ]
Huang, Xiaoli [1 ]
Liang, Jiayu [1 ]
Guan, Shuyu [1 ]
机构
[1] Guangdong Pharmaceut Univ, Coll Tradit Chinese Med, Guangzhou, Peoples R China
关键词
Blood stasis syndrome; Danggui Sini decoction; Intestinal flora; Network pharmacology; EFFICACY;
D O I
10.37290/ctnr2641-452X.21:291-305
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Danggui Sini decoction is a traditional Chinese medicine preparation commonly used in the treatment of blood stasis syndrome through a mechanism yet to be defined. Therefore, we have explored its mechanism of action by combining pharmacology and gut microbiota analysis. To this end, female Sprague-Dawley rats were divided into 5 groups, including the control group, the acute blood stasis group, the Danshen tablet-treated group, the low-dose Danggui Sini decoction group, and the high-dose Danggui Sini decoction group. Danggui Sini decoction led to a significant reduction in the changes in the whole blood viscosity and plasma viscosity of rats with acute blood stasis syndrome, improved the coagulation function and cardiopulmonary pathological injury, upregulated the plasma 6-keto prostaglandin F1a and endothelial nitric oxide synthase, and downregulated thromboxane B2 and endothelin-1. The high throughput 16S rRNA gene sequencing results showed that Danggui Sini decoction reduced the number of pathogenic proteobacteria, significantly reduced erysipelas and suzericella, and increased the beneficial bacteria Roche, effectively improving the status of intestinal flora disorder in acute blood stasis rats. The Spearman correlation analyses showed that there was a close correlation between intestinal flora distribution and changes in blood stasis-related biochemical indices. In addition, network pharmacological analysis showed that the epidermal growth factor receptor, tumor protein p53, signal transducer and activator of transcription 3, vascular endothelial growth factor A, and hypoxia-inducible factor 1-alpha were the core targets of Danggui Sini decoction in alleviation of blood stasis. Further genetic ontological and pathway enrichment analyses suggested that the therapeutic effect of Danggui Sini decoction on blood stasis involved the lipid and atherosclerosis pathways, advanced glycation end-product-receptor for advanced glycation end-product signaling pathways in diabetic complications, fluid shear stress and atherosclerosis pathways, and hypoxia-inducible factors, 1-alpha signaling pathway, phosphatidylinositol 3-kinaseprotein kinase B signaling, and other pathways. These results are helpful in understanding the mechanism by which Danggui Sini decoction improves blood stasis and provide a reference for further research.
引用
收藏
页码:291 / 305
页数:15
相关论文
共 50 条
  • [41] Exploration of the potential mechanism of the Tao Hong Si Wu Decoction for the treatment of postpartum blood stasis based on network pharmacology and in vivo experimental verification
    Xia, Wenwen
    Hu, Shoushan
    Wang, Mengmeng
    Xu, Fan
    Han, Lan
    Peng, Daiyin
    JOURNAL OF ETHNOPHARMACOLOGY, 2021, 268
  • [42] An integrated transcriptomics and network pharmacology approach to explore the mechanism of Wang-Bi tablet against SAPHO syndrome
    Wang, Ting
    Gong, Xun
    Xia, Congmin
    Kong, Weijia
    Geng, Shaohui
    Jiang, Haixu
    Xiao, Enfan
    Wang, Hesong
    Yu, Yingcai
    Li, Chen
    Yuan, Kai
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (02)
  • [43] Network pharmacology and experimental validation to explore the mechanism of Changji'an formula against irritable bowel syndrome with predominant diarrhea
    Ke, Wei
    Wu, Jinjun
    Li, Hongbin
    Huang, Siyu
    Li, Huibiao
    Wang, Yongfu
    Wu, Yingxiu
    Yuan, Jie
    Zhang, Shuncong
    Tang, Hongmei
    Lei, Kaijun
    HELIYON, 2024, 10 (12)
  • [44] Effect of regulating qi and invigorate blood circulation method on hemorrheology in rats with acute blood stasis syndrome and its network pharmacology research
    Mei, Ying
    Feng, Yong
    Zi, Zhaohui
    Pu, Xiang
    2020 ASIA CONFERENCE ON GEOLOGICAL RESEARCH AND ENVIRONMENTAL TECHNOLOGY, 2021, 632
  • [45] Comprehensive Metabolomics and Network Pharmacology to Explore the Mechanism of 5-Hydroxymethyl Furfural in the Treatment of Blood Deficiency Syndrome
    Zhang, Wensen
    Cui, Na
    Su, Fazhi
    Wang, Yangyang
    Yang, Bingyou
    Sun, Yanping
    Guan, Wei
    Kuang, Haixue
    Wang, Qiuhong
    FRONTIERS IN PHARMACOLOGY, 2022, 12
  • [46] Hepatoprotective Mechanism of Ginsenoside Rg1 against Alcoholic Liver Damage Based on Gut Microbiota and Network Pharmacology
    Xia, Ting
    Fang, Bin
    Kang, Chaoyan
    Zhao, Yuxuan
    Qiang, Xiao
    Zhang, Xiaodong
    Wang, Yiming
    Zhong, Tian
    Xiao, Jianbo
    Wang, Min
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2022, 2022
  • [47] Uncovering the Mechanism of the Xingnaojing Injection against Ischemic Stroke Using a Combined Network Pharmacology Approach and Gut Microbiota Analysis
    Liu, Ganlu
    Lin, Jingfeng
    Zhang, Lina
    Gao, Qiang
    Wang, Zhenyi
    Chang, Ze
    Gao, Ying
    Ma, Dayong
    Han, Zhenyun
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [48] Integrating network pharmacology and experimental validation to explore the mitophagy-associated pharmacological mechanism of modified Shisiwei Jianzhong decoction against aplastic anemia
    Zhang, Yun
    Wang, Jun
    Wang, Bo
    Gao, Yanting
    Lin, Shengyun
    Zhou, Yuhong
    Wu, Liqiang
    BIOMEDICAL CHROMATOGRAPHY, 2024,
  • [49] Network Pharmacology Prediction and Molecular Docking-Based Strategy to Explore the Potential Mechanism of Gualou Xiebai Banxia Decoction against Myocardial Infarction
    Wang, Wei-Lu
    Chen, Yan
    GENES, 2024, 15 (04)
  • [50] Combining Network Pharmacology and Experimental Validation to Study the Action and Mechanism of Water extract of Asparagus Against Colorectal Cancer
    Liang, Huiling
    Li, Yanju
    Wang, Feiqing
    Zhao, Jianing
    Yang, Xu
    Wu, Dan
    Zhang, Chike
    Liu, Yanqing
    Huang, Jie
    Su, Min
    He, Zhixu
    Liu, Yang
    Wang, Jishi
    Tang, Dongxin
    FRONTIERS IN PHARMACOLOGY, 2022, 13